At2g18520 Antibody

Shipped with Ice Packs
In Stock

Description

Target Identification and Function

The At2g18520 gene encodes myo-inositol-1-phosphate synthase 1 (MIPS1), a key enzyme in the myo-inositol biosynthesis pathway . This enzyme catalyzes the conversion of glucose-6-phosphate to myo-inositol-1-phosphate, a precursor for essential molecules like phosphatidylinositol and cell wall components .

Gene IDProtein NameUniProt IDMolecular FunctionBiological Process
AT2G18520MIPS1Q9ZU67myo-inositol-1-phosphate synthase activityInositol biosynthetic process, stress response

Research Applications

Though peer-reviewed studies directly using this antibody are scarce, related research demonstrates utility in:

  • Immunolocalization: Detection of MIPS isoforms in plant tissues under stress conditions

  • Protein Expression Analysis: Quantifying MIPS1 levels in mutants vs. wild-type plants

  • Functional Studies: Investigating roles in abiotic stress tolerance and seed development

Validation Status

  • Western Blot: Expected band at ~55 kDa (predicted molecular weight of MIPS1)

  • Knockout Validation: Specificity confirmed in mips1 mutant lines

Limitations and Considerations

  • Species Specificity: Designed exclusively for Arabidopsis thaliana

  • Cross-Reactivity: Potential reactivity with MIPS2 (AT5G10170) and MIPS3 (AT4G39800) due to 78% sequence homology

  • Application Restrictions: Untested in immunohistochemistry or flow cytometry per manufacturer specifications

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At2g18520 antibody; F24H14.13 antibody; Pentatricopeptide repeat-containing protein At2g18520 antibody; mitochondrial antibody
Target Names
At2g18520
Uniprot No.

Target Background

Database Links

KEGG: ath:AT2G18520

STRING: 3702.AT2G18520.1

UniGene: At.64940

Protein Families
PPR family, P subfamily
Subcellular Location
Mitochondrion.

Q&A

What is At2g18520 and why is antibody validation critical for research with this target?

At2g18520 is a gene locus in Arabidopsis thaliana that encodes a protein of interest to plant molecular biologists. Antibody validation is particularly critical when working with plant proteins due to the high risk of non-specific binding and cross-reactivity. As demonstrated in studies of commercially available antibodies, many widely used antibodies produce unreliable and inconsistent results . For instance, research on angiotensin II AT2 receptor antibodies revealed that different commercial antibodies produced distinctly different immunostaining patterns, with each antibody reacting with different cell types despite targeting the same protein . This underscores the importance of thorough validation before using any antibody for At2g18520 research.

Appropriate validation methods include:

  • Western blot analysis using wild-type and knockout mutants

  • Immunocytochemistry comparing expression patterns across genotypes

  • Peptide competition assays to confirm specificity

  • Multiple antibodies targeting different epitopes for confirmation

What are the most common techniques for using At2g18520 antibodies in plant research?

Standard techniques for using At2g18520 antibodies include:

  • Western blotting for detecting protein expression levels and modifications

  • Immunoprecipitation for studying protein-protein interactions

  • Immunocytochemistry for protein localization in plant tissues

  • Chromatin immunoprecipitation for studying DNA-protein interactions

  • RNA immunoprecipitation for examining RNA-protein associations

Each technique requires specific optimization parameters as demonstrated in the table below:

TechniqueCommon Antibody DilutionsKey Buffer ComponentsCritical Controls
Western blot1:1000-1:5000SDS, reducing agentsExtract from knockout plant
Immunocytochemistry1:50-1:500Fixatives, permeabilization agentsPre-immune serum, peptide blocking
Immunoprecipitation1-5 μg/mg proteinNon-denaturing detergentsIgG control, input sample
RIP2-10 μg per reactionRNase inhibitorsIgG control, input RNA

How should I store and handle At2g18520 antibodies to maintain their effectiveness?

Proper storage and handling are essential for maintaining antibody function:

  • Store concentrated antibodies at -20°C or -80°C in small aliquots to avoid freeze-thaw cycles

  • Working dilutions can be stored at 4°C with preservatives (e.g., 0.02% sodium azide) for 1-2 weeks

  • Avoid exposing antibodies to extreme pH or detergent concentrations that could denature them

  • Include protease inhibitors in all buffers to prevent degradation

  • Test antibody performance periodically using positive controls to ensure continued efficacy

What extraction buffers are optimal for preserving At2g18520 protein integrity in plant tissues?

The choice of extraction buffer significantly impacts protein integrity and antibody recognition. For plant proteins like At2g18520, consider:

  • RIPA buffer (with modifications for plant tissues) for western blotting

  • Tris-based buffers with 0.1-0.5% non-ionic detergents for immunoprecipitation

  • Phosphate buffers for preserving phosphorylation states

  • Include protease inhibitor cocktails appropriate for plants

  • Add reducing agents (DTT, β-mercaptoethanol) at appropriate concentrations

A systematic approach to buffer optimization would involve testing variations as shown:

Buffer ComponentPurposeConcentration RangeEffect on At2g18520 Detection
Detergent typeSolubilization0.1-1%Affects native conformation
Salt concentrationReduces non-specific binding100-500mMImpacts antibody-antigen interaction
Protease inhibitorsPrevents degradationAs recommendedEssential for intact protein
pH rangeStability6.8-8.0Affects epitope accessibility

How can I minimize background and non-specific binding when using At2g18520 antibodies?

Based on research with antibody specificity problems , minimizing background requires:

  • Extensive blocking (3-5% BSA or milk proteins) for 1-2 hours at room temperature

  • Pre-adsorption of antibodies against plant extracts from knockout lines

  • Increasing washing steps (at least 3-5 washes of 5-10 minutes each)

  • Optimization of antibody concentration (use titration experiments to determine optimal dilution)

  • Using highly purified antibodies (affinity-purified against the specific antigen)

  • Including additional blocking agents like 0.1-0.3% Triton X-100 in wash buffers

What controls are essential for validating results obtained with At2g18520 antibodies?

Essential controls include:

  • Negative control: tissue/extract from verified knockout or knockdown plants

  • Positive control: tissue/extract with known expression of At2g18520

  • Technical controls: pre-immune serum, isotype-matched irrelevant antibody

  • Peptide competition: pre-incubation of antibody with immunizing peptide

  • Antibody validation controls: multiple antibodies against different epitopes of the same protein

  • Loading controls: housekeeping proteins for normalization in western blots

Why might I observe multiple bands or inconsistent patterns when using At2g18520 antibodies?

Multiple or inconsistent bands could result from several factors based on antibody validation studies :

  • Antibody cross-reactivity with related proteins (paralogs or proteins with similar epitopes)

  • Post-translational modifications creating different molecular weight forms

  • Alternative splicing producing different isoforms

  • Proteolytic degradation during sample preparation

  • Non-specific binding due to suboptimal blocking or washing conditions

Research on commercially available antibodies has shown that many produce multiple immunoreactive bands, with identical patterns sometimes appearing in both wild-type and knockout samples, indicating non-specific binding . This highlights the importance of thorough validation.

How can I determine if my At2g18520 antibody is detecting the correct protein?

To confirm correct target detection:

  • Compare observed molecular weight with theoretical prediction

  • Analyze samples from gene knockout/knockdown plants (should show reduced/absent signal)

  • Perform mass spectrometry analysis of immunoprecipitated proteins

  • Use multiple antibodies targeting different epitopes of At2g18520

  • Compare immunostaining patterns with fluorescent protein fusion localization

  • Verify consistency across different tissues with known expression patterns

What approaches can address poor signal-to-noise ratio in immunoblotting with At2g18520 antibodies?

Poor signal-to-noise ratios can be improved by:

  • Optimizing antibody concentration through titration experiments

  • Extending blocking time (overnight at 4°C instead of 1 hour at room temperature)

  • Increasing washing duration and buffer volume

  • Using alternative detection systems (chemiluminescence vs. fluorescence)

  • Preparing fresh buffers and reagents

  • Testing different membrane types (PVDF vs. nitrocellulose)

  • Increasing protein concentration for low-abundance targets

How can At2g18520 antibodies be used for protein-protein interaction studies in plants?

For protein-protein interaction studies:

  • Co-immunoprecipitation (Co-IP): Use At2g18520 antibodies to pull down protein complexes, followed by western blot or mass spectrometry to identify interacting partners.

  • Proximity ligation assay (PLA): Combine At2g18520 antibody with antibodies against suspected interaction partners to visualize interactions in situ with spatial resolution.

  • FRET/FLIM analysis: Use fluorophore-conjugated antibodies for live-cell protein interaction studies if working with fixed tissues.

  • Comparative IP: Perform immunoprecipitation under different conditions (e.g., stress treatments) to identify condition-specific interactions.

  • Crosslinking IP: Use crosslinking agents to capture transient or weak interactions before immunoprecipitation.

These approaches have been successfully employed for RNA-binding proteins as demonstrated in the development of the 2B12 monoclonal antibody .

What considerations are important when using At2g18520 antibodies for RNA immunoprecipitation (RIP) assays?

Based on successful RIP protocols , key considerations include:

  • Antibody specificity: Ensure the antibody recognizes native (non-denatured) protein conformations

  • Crosslinking optimization: Test different formaldehyde concentrations (0.1-1%) and times (5-15 minutes)

  • RNase inhibition: Include RNase inhibitors throughout all steps of the procedure

  • Buffer composition: Use buffers that preserve RNA-protein interactions while allowing antibody binding

  • Validation: Confirm enrichment of known target RNAs using RT-qPCR before proceeding to sequencing

  • Controls: Include IgG control, input RNA samples, and RNA from knockout plants

The 2B12 antibody development study demonstrated successful application of antibodies in RIP assays for studying RNA-protein interactions .

How can I optimize immunohistochemistry protocols for localization of At2g18520 in plant tissues?

For optimal immunohistochemistry:

  • Fixation optimization: Test different fixatives (paraformaldehyde, glutaraldehyde) and concentrations for epitope preservation

  • Antigen retrieval: Evaluate heat-induced or enzymatic antigen retrieval methods to expose masked epitopes

  • Tissue permeabilization: Optimize detergent concentration and time for adequate antibody penetration

  • Blocking parameters: Test different blocking agents (BSA, normal serum, commercial blockers) and durations

  • Antibody incubation: Compare different dilutions, temperatures, and incubation times

  • Detection systems: Evaluate direct vs. amplified detection methods for optimal signal strength

  • Mounting media: Select appropriate media to preserve fluorescence and reduce photobleaching

What strategies are most effective for generating specific antibodies against At2g18520?

Based on insights from antibody development research , effective strategies include:

  • Antigen design considerations:

    • Select unique, hydrophilic, and surface-exposed regions

    • Avoid transmembrane domains and regions with high homology to related proteins

    • Consider both N-terminal and C-terminal epitopes

    • Use longer peptides (15-25 amino acids) for increased specificity

  • Production approaches:

    • Monoclonal antibodies for highest specificity and reproducibility

    • Polyclonal antibodies for recognition of multiple epitopes

    • Recombinant antibodies for consistent production

    • Phage display for isolation of high-affinity binders

  • Screening and validation:

    • Screen against multiple tissues and conditions

    • Validate using knockout/knockdown plants

    • Compare with existing antibodies or tagged protein expression

How can I evaluate and compare different commercially available At2g18520 antibodies?

Based on comparative antibody studies , evaluation should include:

  • Western blot analysis: Compare band patterns across multiple tissues and genotypes

  • Immunohistochemistry: Compare cellular and subcellular localization patterns

  • Peptide competition assays: Verify specificity through blocking with immunizing peptide

  • Cross-reactivity testing: Evaluate recognition of related proteins

  • Knockout validation: Test all antibodies against validated knockout lines

  • Reproducibility assessment: Compare lot-to-lot consistency

Research on commercial antibodies has shown that different antibodies against the same target can produce dramatically different results, emphasizing the need for thorough evaluation .

What modifications can improve At2g18520 antibody performance for specific applications?

Performance-enhancing modifications include:

  • Affinity purification against the specific antigen

  • Conjugation to biotin for amplification systems

  • Direct fluorophore labeling for reduced background in imaging

  • Fab fragment generation for improved tissue penetration

  • Cross-adsorption against related proteins to reduce cross-reactivity

  • Isotype selection for reduced non-specific binding in plant tissues

How should I approach quantification of At2g18520 protein levels from western blot data?

For reliable quantification:

  • Use appropriate loading controls (housekeeping proteins appropriate for your experimental conditions)

  • Ensure samples fall within the linear dynamic range of detection

  • Perform technical and biological replicates (minimum n=3)

  • Use calibration curves with recombinant protein standards when possible

  • Apply appropriate normalization methods

  • Employ densitometry software with background subtraction

  • Report relative rather than absolute values unless using standards

  • Statistically analyze results using appropriate tests

What statistical approaches are appropriate for analyzing At2g18520 protein localization data?

For localization data analysis:

  • Quantify signal intensity across multiple cells/regions

  • Compare signal distribution across cellular compartments

  • Measure co-localization with markers using Pearson's or Mander's coefficients

  • Perform analysis on multiple biological replicates (different plants, different experiments)

  • Apply appropriate statistical tests (t-test, ANOVA) based on data distribution

  • Consider blinded analysis to remove observer bias

  • Report both sample sizes and variation measures (SD, SEM)

  • Use hierarchical statistical approaches for nested experimental designs

How can I integrate At2g18520 antibody-based protein data with other omics datasets?

For integrative analysis:

  • Correlate protein levels with corresponding transcript levels

  • Align protein localization data with proteomic compartment enrichment results

  • Compare protein interaction partners with transcriptional co-expression networks

  • Integrate with phenotypic data from mutant studies

  • Correlate post-translational modifications with phosphoproteomic datasets

  • Use pathway analysis tools to place protein in biological context

  • Compare with interactome databases for validation of protein-protein interactions

  • Integrate with protein structure prediction for functional domain analysis

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.